The Drugs for Immunotherapy Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Drugs for Immunotherapy Market:
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
According to The Business Research Company’s Drugs for Immunotherapy Global Market Report 2024, The drugs for immunotherapy market size has grown rapidly in recent years. It will grow from $255.14 billion in 2023 to $281.43 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rising incidence of cancer, unmet medical needs, cancer immunotherapy awareness, higher adoption rates of immunotherapeutic approaches, rising investment by pharmaceutical giants.
The drugs for immunotherapy market size is expected to see rapidly grown in the next few years. It will grow to $445.12 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to combination therapies, personalized medicine, global expansion, biomarker-driven therapies, increasing clinical trials. Major trends in the forecast period include advancements in immunology, advancements in car-t cell therapies, targeted immunotherapies, immunotherapy combinations, neoantigen vaccines.
The drugs for immunotherapy market is being driven by rising incidences of cancer globally. The major causes of most cancers include obesity, smoking, alcohol, and improper eating habits. For instance, in October 2022, Macmillan Cancer Support, the largest UK-based health care charity organization, it is estimated that there will be 3.5 million people with cancer by 2025, 4 million by 2030, and 5.3 million by 2040. Breast, lung, colon, rectum, and prostate cancers are the most prevalent types of cancer. The use of tobacco, having a high body mass index, drinking alcohol, eating few fruits and vegetables, and not exercising account for about one-third of cancer-related fatalities. The rising incidences of cancer are expected to increase the demand for immunotherapy drugs driving the drugs for immunotherapy market growth.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2559&type=smp
The drugs for immunotherapy market covered in this report is segmented –
1) Drugs for Immunotherapy Market By Type: Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types
2) Drugs for Immunotherapy Market By Therapy Area: Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas
3) Drugs for Immunotherapy Market By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users
Top Major Players
F. Hoffmann-La Roche Ltd.
Novartis AG
Amgen Inc.
AbbVie Inc.
Merck & Co. Inc.
Product innovations are a key trend gaining popularity in the equity-indexed life insurance market. Major companies operating in the equity-indexed life insurance market are focused on developing innovative solutions to strengthen their position in the market. For instance, in December 2021, Sun Life International, a Canada-based financial services organization, launched a new index universal life insurance product, Sun Global Solis. The new product provides worldwide ultra-high net worth (UHNW) and high net worth (HNW) clients with a blend of long-term protection and upside potential. This product’s unique features include competitive indexed account cap rate choices, a 2% cumulative guarantee that may boost the cash surrender value, access to liquidity via loans and partial surrenders after the first contract anniversary, and no-cost extended issue age and dollar cost averaging.
The drugs for immunotherapy market report table of contents includes:
1. Executive Summary
2. Drugs For Immunotherapy Market Characteristics
3. Drugs For Immunotherapy Market Trends And Strategies
4. Drugs For Immunotherapy Market – Macro Economic Scenario
5. Global Drugs For Immunotherapy Market Size and Growth
……
31. Global Drugs For Immunotherapy Market Competitive Benchmarking
32. Global Drugs For Immunotherapy Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Drugs For Immunotherapy Market
34. Drugs For Immunotherapy Market Future Outlook and Potential Analysis
35. Appendix
Read Related Reports:
https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
